Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Graphene Functionalisation Capabilities

17 Mar 2014 07:00

RNS Number : 3620C
Oxford Advanced Surfaces Group PLC
17 March 2014
 



OXFORD ADVANCED SURFACES GROUP PLC

(AIM: OXA)

 

OAS announces graphene functionalisation capabilities

 

Oxford Advanced Surfaces Group (OAS), the AIM listed technology developer targeting engineered materials and surface modification applications in multiple markets including automotive, aerospace, communications and renewable energy, announces that it is developing capabilities to functionalise graphene using its proprietary Onto™ technology platform.

 

OAS is now investigating the use of Onto™ to modify graphene chemically for multiple applications. The ability to modify both the dispersibility/affinity of the graphene for a solvent or coating, and to improve the chemical interaction and adhesion of the graphene within a coating, is a powerful tool in the production of commercially relevant graphene-based applications and products.

 

OAS is researching the applications and requirements for chemically modified graphene in areas such as composites and electronics. In addition OAS is actively seeking partners for co-development of commercial applications with both graphene suppliers/manufactures as well as end users, converters and specifiers.

 

Graphene holds massive promise. Possessing a unique portfolio of desirable properties, including excellent conductivity, mechanical strength, gas barrier, thermal and biocompatibility, graphene is an intriguing material. One of the obstacles to realising graphene's potential is the need to functionalise with the minimum disruption to the intrinsic properties. This can be achieved by the chemical modification of graphene to impart the desired chemical properties to the platelets. The use of functional graphene is a fundamental part of new product design and should be factored into the plan for the product in the earliest stages of development.

 

Philip Spinks, CEO, commented:

 

"This is a significant development in the OAS Onto™ toolkit and could open significant emerging markets for OAS and graphene manufacturers and potential end users."

 

Jon-Paul Griffiths, Technical Manager, commented:

 

"The use of graphene in applications such as electronics and composites is an exciting prospect as seen by the materials community. Success relies heavily on the ability to combine graphene with other materials using commercially accepted manufacturing processes. The chemical modification of graphene using the OntoTM technology platform provides a significant potential to open up commercial applications for this exciting material."

 

17 March 2014

 

Enquiries:

 

Oxford Advances Surfaces Group Plc

www.oxfordsurfaces.com

 

Philip Spinks, Chief Executive Officer T: 01865 854 807

 

W H Ireland Limited

www.wh-ireland.co.uk

 

John Wakefield T: 0117 945 3471

 

 

Editors' Note

Oxford Advanced Surfaces Group (OAS) is the AIM listed technology developer targeting engineered materials and surface modification applications in multiple markets including automotive, aerospace, communications and renewable energy. Our proprietary Onto™ highly reactive chemistry provides manufacturers with solutions for the surface functionalisation and adhesion promotion of coatings, inks and adhesives to difficult-to-bond substrates. Onto™ is processed from solution using typical wet process techniques and can be integrated into customer manufacturing lines for use in a wide range of surface modification applications for high-performance plastics, low surface energy polymers and composites.

Onto™ technology creates permanent bonding to surfaces through the use of highly reactive carbene chemistry. Carbenes can react with almost anything, even difficult-to-bond materials with limited or no functionality such as polyethylene, making Onto™ a diverse surface modification technology for a wide range of materials. The chemistry is flexible and can be manipulated to provide a variety of properties to a surface, giving it scope for use in a broad range of applications and markets.

At OAS, we have the expertise, know-how and facilities to design and synthesise Onto™ materials and formulations that provide functional surface treatments to meet specific performance and processing requirements. We currently have one development product available to the market, EP1000, and we are working on a range of product to address further identified manufacturing needs.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUQAWUPCGWC
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.